Clinically Relevant Drug Interactions in the Cancer Setting
David DeRemer, PharmD, BCOP, FCCP, FHOPA
From University of Florida Health Cancer Center, Gainesville, Florida
Presenter’s disclosure of conflicts of interest is found at the end of this article.
J Adv Pract Oncol 2022;13(3):231–235 |
© 2022 Harborside™
Along with the fast pace of oncology drug approvals is the heightened opportunity for drug-drug, drug-food, and drug-herbal interactions. Attendees at the JADPRO Live Virtual 2021 conference learned about the pharmacodynamic and pharmacokinetic mechanisms of drug interactions and how to integrate appropriate therapeutic management strategies to optimize patient care and minimize the potential outcomes of severe drug interactions.
For access to the full length article, please sign in